ONS Publishes Manual on Psychosocial Aspects of Oncology Care

Publication
Article
OncologyONCOLOGY Vol 12 No 2
Volume 12
Issue 2

The Oncology Nursing Society (ONS) announces the publication of Psychosocial Dimensions of Oncology Nursing Care. The module, which will be available in early 1998, addresses the psychosocial aspects that affect the patient with cancer and provides practical interventions.

The Oncology Nursing Society (ONS) announces the publication of Psychosocial Dimensions of Oncology Nursing Care. The module, which will be available in early 1998, addresses the psychosocial aspects that affect the patient with cancer and provides practical interventions.

The module is designed as a broad overview of common psychosocial concerns in cancer care and provides a review of assessment techniques and practical strategies to assist patients, families, and caregivers. The major subject headings include:

  • Coping with cancer;
  • Patient and family issues;
  • Spirituality;
  • Survivorship;
  • Sexuality;
  • Body image;
  • Death, dying, and bereavement;
  • Alterative therapies; and
  • Self-care for nurses.

Within each of these subject headings are detailed and specific strategies and suggestions for dealing with the day-to-day problems faced by patients and their families.

The manual can be purchased for $15 (ONS member) and $18 (nonmember). To order the manual, contact: ONS Customer Service Department, 501 Holiday Drive, Pittsburgh, PA 15220, or call (412) 921-7373.

Recent Videos
Historical standards for H3 K27M-mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD.
2 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
Dordaviprone was recommended at a dose of 625 mg orally once weekly for adults, and the recommended dosage is based on body weight for pediatric patients.
Extended follow-up for individuals with H3 K27M-mutated diffuse midline glioma may help explain the duration of response across patient subgroups.